Jul 11, 2026 | News
July 10, 2026 – The U.S. Food and Drug Administration today issued a proposed rule that, if finalized, would create a streamlined registration pathway for distributed manufacturing establishments that operate as a single establishment using a “hub-and-spoke”...Jul 11, 2026 | News
This link includes the formal press release – Office of Public Affairs | Justice Department Places FDA-Approved Marijuana Products and Products Containing Marijuana Subject to a Qualifying State-issued License in Schedule III, Strengthening Medical Research...Jul 2, 2026 | News
July 1, 2026 – Yesterday the U.S. Drug Enforcement Administration filed its intent to temporarily place 7-hydroxymitagynine (7-OH) and three related substances into Schedule I of the Controlled Substances Act (CSA). Prior to DEA issuing this notice, the...Jun 5, 2026 | News, PMP
May 20, 2026 – The Department of Veterans Affairs published a proposed rule in the Federal Register (Document Citation 91 FR 29407 [federalregister.gov]). The Summary Reads, “The Department of Veterans Affairs (VA) proposes to amend its regulation that governs...May 31, 2026 | News
The DEA will hold a hearing with respect to the proposed rescheduling of marijuana into schedule III of the Controlled Substances Act beginning June 29, 2026. The hearing will begin on June 29, 2026, and will conclude not later than July 15, 2026. See Fed. Reg. Vol....May 5, 2026 | News
May 4, 2026 – The Office of National Drug Control Policy today released the 2026 National Drug Control Strategy. The document includes a number of references to counterfeit drugs and online purchase of medications. To read/download the full report click...